McCourt Marion — SEC insider filings
SEC reporting owner CIK 1663758. 60 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers the 50 most recent of 60 filings on record, filed 2021-12-10 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 56 legs across 42 filings — 35,977 shares, $28,622,443 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 74.
- Largest priced transaction: sale of 1,137 shares @ $1,060.86 ($1,206,198) in REGENERON PHARMACEUTICALS, INC., filed 2024-08-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | EVP Commercial | 50 | — | 56 legs · 35,977 sh · $28,622,443 | 74 |
Insider filings — McCourt Marion
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 44 @ $952.79 · Sale (S): 59 @ $954.46 · Sale (S): 30 @ $955.51 · Sale (S): 22 @ $956.01 · Sale (S): 44 @ $958.47 · Sale (S): 66 @ $959.46 · +7 more | EDGAR |
| 2026-11-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,132 @ $869.43 | EDGAR |
| 2026-09-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,215 @ $850 · Sale (S): 1,131 @ $857.39 | EDGAR |
| 2025-12-11 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 1,021 @ $701.51 | EDGAR |
| 2025-12-09 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 2,476 @ $0 · Tax withholding (F): 1,336 @ $712.94 · Grant/award (A): 12,210 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 759 @ $730.81 | EDGAR |
| 2024-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 2,332 @ $0 · Tax withholding (F): 274 @ $787 · Grant/award (A): 8,981 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $381.40 · Sale (S): 1,000 @ $844.61 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $381.40 · Sale (S): 1,000 @ $1,054.06 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $381.40 · Sale (S): 1,000 @ $1,178.73 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,137 @ $372.46 · Sale (S): 1,137 @ $1,060.86 · Option exercise (M): 1,137 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,137 @ $372.46 · Sale (S): 1,137 @ $1,047.11 · Option exercise (M): 1,137 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,138 @ $372.46 · Sale (S): 1,138 @ $980.16 · Option exercise (M): 1,138 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 250 @ $889.41 | EDGAR |
| 2024-04-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 250 @ $964.73 | EDGAR |
| 2024-03-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 358 @ $967.50 | EDGAR |
| 2024-02-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,000 @ $934.71 | EDGAR |
| 2024-02-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 273 @ $945.61 | EDGAR |
| 2024-01-04 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 274 @ $873.91 | EDGAR |
| 2023-12-14 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 5,105 @ $856.71 | EDGAR |
| 2023-12-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 852 @ $843.79 · Grant/award (A): 2,133 @ $0 · Sale (S): 270 @ $838.44 · Tax withholding (F): 373 @ $844.09 · Grant/award (A): 7,649 (derivative) @ $0 | EDGAR |
| 2023-11-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $381.40 · Sale (S): 1,000 @ $783.91 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,038 @ $372.46 · Sale (S): 1,038 @ $827 · Option exercise (M): 1,038 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 250 @ $834.55 | EDGAR |
| 2023-08-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 250 @ $744.66 | EDGAR |
| 2023-07-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 250 @ $710.09 | EDGAR |
| 2023-06-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 250 @ $736 | EDGAR |
| 2023-04-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $372.46 · Sale (S): 1,100 @ $818.80 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $372.46 · Sale (S): 1,100 @ $759.89 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2023-02-14 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 1,276 @ $751.78 | EDGAR |
| 2023-02-08 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $372.46 · Sale (S): 1,000 @ $769.04 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2023-02-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $372.46 · Sale (S): 1,100 @ $752.19 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $372.46 · Sale (S): 1,100 @ $721.86 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2022-12-20 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 2,973 @ $0 · Grant/award (A): 10,971 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 274 @ $753.28 · Sale (S): 264 @ $730.17 | EDGAR |
| 2022-12-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $372.46 · Sale (S): 1,100 @ $756.19 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2022-11-07 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $372.46 · Sale (S): 1,000 @ $727.82 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2022-11-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $372.46 · Sale (S): 1,100 @ $750 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2022-10-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 600 @ $372.46 · Sale (S): 600 @ $705.39 · Option exercise (M): 500 @ $342.93 · Sale (S): 500 @ $705.39 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 600 (derivative) @ $0 | EDGAR |
| 2022-09-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $342.93 · Sale (S): 1,100 @ $577.62 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2022-08-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $342.93 · Sale (S): 1,100 @ $581.53 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2022-07-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $342.93 · Sale (S): 1,100 @ $587.76 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $342.93 · Sale (S): 1,100 @ $669.51 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2022-05-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,100 @ $342.93 · Sale (S): 1,100 @ $656.97 · Option exercise (M): 1,100 (derivative) @ $0 | EDGAR |
| 2022-04-04 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $342.93 · Sale (S): 1,000 @ $701.82 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2022-03-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $342.93 · Sale (S): 1,000 @ $615.39 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2022-02-02 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $342.93 · Sale (S): 1,000 @ $607.46 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $342.93 · Sale (S): 1,000 @ $625 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 388 @ $664.34 · Sale (S): 344 @ $653.12 | EDGAR |
| 2021-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 3,338 @ $0 · Grant/award (A): 14,253 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1663758 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs